Bioalpha Holdings Berhad (KLSE:BIOHLDG)
Malaysia · Delayed Price · Currency is MYR 0.0200
0.00 (0.00%)
At close: Jun 30, 2026
Bioalpha Holdings Berhad Income Statement
Financials in millions MYR. Fiscal year is January - December.
Millions MYR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 11.39 | 11.48 | 62.02 | 46.09 | 35.8 | 96.72 | |
Revenue Growth (YoY) | -80.12% | -81.49% | 34.58% | 28.75% | -62.99% | 165.26% |
Cost of Revenue | 11.41 | 12.47 | 65.8 | 45.96 | 41.78 | 82.67 |
Gross Profit | -0.03 | -0.99 | -3.78 | 0.12 | -5.98 | 14.05 |
Selling, General & Admin | 23.39 | 21.97 | 42.06 | 43.89 | 31.86 | 18.94 |
Other Operating Expenses | 8.3 | 10.85 | 12.06 | 0.83 | 10.22 | -2.68 |
Operating Expenses | 31.69 | 32.82 | 54.12 | 44.72 | 42.08 | 16.26 |
Operating Income | -31.72 | -33.81 | -57.9 | -44.59 | -48.06 | -2.2 |
Interest Expense | -0.24 | -0.25 | -0.37 | -0.69 | -0.77 | -0.57 |
Interest & Investment Income | 0.06 | 0.06 | 0.23 | - | - | - |
Earnings From Equity Investments | 0.03 | 0.03 | -0.06 | -0.01 | - | - |
Currency Exchange Gain (Loss) | 0.01 | 0.01 | 0.01 | - | - | - |
EBT Excluding Unusual Items | -31.85 | -33.95 | -58.08 | -45.28 | -48.83 | -2.77 |
Gain (Loss) on Sale of Assets | 0.02 | 0.02 | 0.05 | - | - | - |
Other Unusual Items | 0.01 | 0.01 | 0.1 | - | - | - |
Pretax Income | -31.82 | -33.92 | -57.93 | -45.28 | -48.83 | -2.77 |
Income Tax Expense | -3.87 | -4.02 | -1.6 | -1.63 | -0.04 | -1.25 |
Earnings From Continuing Operations | -27.95 | -29.9 | -56.34 | -43.65 | -48.79 | -1.52 |
Earnings From Discontinued Operations | -0.05 | -0.05 | 5.84 | - | - | - |
Net Income to Company | -28.01 | -29.95 | -50.49 | -43.65 | -48.79 | -1.52 |
Minority Interest in Earnings | 0.31 | 0.27 | 1.94 | 1.65 | 0.96 | 0.24 |
Net Income | -27.7 | -29.68 | -48.55 | -42 | -47.83 | -1.29 |
Net Income to Common | -27.7 | -29.68 | -48.55 | -42 | -47.83 | -1.29 |
Shares Outstanding (Basic) | 1,263 | 1,264 | 1,264 | 1,264 | 1,261 | 1,156 |
Shares Outstanding (Diluted) | 1,263 | 1,264 | 1,264 | 1,264 | 1,261 | 1,196 |
Shares Change (YoY) | -0.07% | - | - | 0.24% | 5.41% | 22.87% |
EPS (Basic) | -0.02 | -0.02 | -0.04 | -0.03 | -0.04 | -0.00 |
EPS (Diluted) | -0.02 | -0.02 | -0.04 | -0.03 | -0.04 | -0.00 |
Free Cash Flow | -4.29 | -6.27 | -1.14 | -1.75 | -6.95 | -13.62 |
Free Cash Flow Per Share | -0.00 | -0.01 | -0.00 | -0.00 | -0.01 | -0.01 |
Gross Margin | -0.24% | -8.63% | -6.09% | 0.27% | -16.71% | 14.53% |
Operating Margin | -278.55% | -294.41% | -93.34% | -96.76% | -134.26% | -2.28% |
Profit Margin | -243.27% | -258.44% | -78.28% | -91.13% | -133.62% | -1.33% |
Free Cash Flow Margin | -37.70% | -54.60% | -1.83% | -3.79% | -19.42% | -14.08% |
EBITDA | -28.86 | -30.45 | -50.19 | -36.88 | -39.21 | 6.59 |
EBITDA Margin | -253.44% | -265.20% | -80.92% | -80.02% | -109.54% | 6.82% |
D&A For EBITDA | 2.86 | 3.35 | 7.7 | 7.71 | 8.85 | 8.8 |
EBIT | -31.72 | -33.81 | -57.9 | -44.59 | -48.06 | -2.2 |
EBIT Margin | -278.55% | -294.41% | -93.34% | -96.76% | -134.26% | -2.28% |